Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-controlled, Multicenter, Multinational Study to Evaluate the Efficacy and Safety of Zemaira® Administration in Chronic Augmentation and Maintenance Therapy in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency Who Completed Clinical Study CE1226_4001

NCT00670007 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00670007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00670007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-controlled, Multicenter, Multinational Study to Evaluate the Efficacy and Safety of Zemaira® Administration in Chronic Augmentation and Maintenance Therapy in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency Who Completed Clinical Study CE1226_4001
Lead sponsor
CSL Behring
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
September 30, 2014
Enrollment
140 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

alpha 1-proteinase inhibitor deficiency, emphysema